MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in cash
-$4,285K
Increase (decrease) in
accrued expenses and...
$328K
Decrease in other current
assets
-$54K
Deferred income taxes
$17K
Net cash (used in)
provided by operating...
-$3,010K
Net cash used in
financing activities
-$1,275K
Canceled cashflow
$399K
Net (loss) income
-$3,409K
Preferred stock dividend
payments
$1,275K
Back
Back
Cash Flow
source: myfinsight.com
ENZON PHARMACEUTICALS, INC. (ENZN)
ENZON PHARMACEUTICALS, INC. (ENZN)